Systematic ReviewPublished 9 October 2026Comparative effectiveness and safety of almonertinib in EGFR-mutated non-small cell lung cancer: an integrated evidence synthesisBiaoxue Rong · Hui Pan · Tian Fu · Yanfeng Liu · Pan Yang · Jiaying Zhang · Ying WangFrontiers in Pharmacologydoi 10.3389/fphar.2026.1932051